Preliminary research suggests Leukemia drug could also treat Par - KWWL - Eastern Iowa Breaking News, Weather, Closings

Preliminary research suggests Leukemia drug could also treat Parkinson's disease

Posted: Updated:
WASHINGTON, D.C. (KWWL) -

It is very early in the process, but promising research has been released regarding Parkinson's disease.

A 12-patient group diagnosed with Parkinson's at Georgetown University Medical Center in the nation's capital is the basis of the study, which has centered around treatment with a drug that is typically used to treat Leukemia.

The drug is called "Nilotinib," and doctors say it appears to have reversed at least some of the disease's symptoms in nearly every one of the patients involved in the study.

Researchers do say that the study is merely preliminary in form and that embracing the results should be tempered for now, as the 12 patients were not compared to a larger control group.

More widespread studies will be required to confirm the results, but the research is scheduled to be presented at an annual meeting for the Society for Neuroscience.

Powered by Frankly